









Markets
/
Stocks
/
nasdaq-cor
/

Cencora Inc

COR

341.210USD

+8.040+2.41%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

66.15BMarket Cap

34.86P/E TTM



Cencora Inc

341.210

+8.040+2.41%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Cencora Inc

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cencora Inc's Score

Industry at a Glance

Industry Ranking

1 / 210

Overall Ranking

17 / 4621

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 18 analysts

Buy

Current Rating

338.872

Target Price

+1.71%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Cencora Inc Highlights

StrengthsRisks

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 293.96B.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 23.21% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 27.58%.

Overvalued

The company’s latest PE is 34.75, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 181.51M shares, decreasing 0.88% quarter-over-quarter.

Held by Andreas Halvorsen

Star Investor Andreas Halvorsen holds 2.08M shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 7.72, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 80.66B, representing a year-over-year increase of 8.65%, while its net profit experienced a year-over-year increase of 42.18%.

Score

Industry at a Glance

Previous score

7.72

Change



Financials

9.27

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.03

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.81

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.61

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

6.87

Key Metrics

Free cash flow

No Data

Cencora Inc's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 8.18, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 34.75, which is 11.26% below the recent high of 38.66 and 48.85% above the recent low of 17.78.

Score

Industry at a Glance

Previous score

8.18

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 1/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 7.89, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Cencora Inc is 345.00, with a high of 380.00 and a low of 279.21.

Score

Industry at a Glance

Previous score

7.89

Change

Support & Resistance

No Data

Analyst Rating

Based on 18 analysts

Buy

Current Rating

338.872

Target Price

+1.71%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Cencora Inc

COR

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 9.49, which is higher than the Healthcare Equipment & Supplies industry's average of 6.55. Sideways: Currently, the stock price is trading between the resistance level at 362.42 and the support level at 308.04, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.54

Change

-0.05

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MACD(12,26,9)

1.978

Buy

RSI(14)

74.834

Buy

STOCH(KDJ)(9,3,3)

74.218

Sell

ATR(14)

6.252

Low Volatility

CCI(14)

171.330

Buy

Williams %R

25.081

Buy

TRIX(12,20)

0.427

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

335.756

Buy

MA10

331.904

Buy

MA20

322.624

Buy

MA50

307.388

Buy

MA100

300.178

Buy

MA200

284.858

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 93.62%, representing a quarter-over-quarter decrease of 5.19%. The largest institutional shareholder is The Vanguard, holding a total of 22.40M shares, representing 11.55% of shares outstanding, with 5.19% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

22.40M

+5.26%

BlackRock Institutional Trust Company, N.A.

12.03M

+9.29%

State Street Investment Management (US)

8.41M

-0.08%

Walgreens Boots Alliance Inc

7.47M

-28.01%

T. Rowe Price Associates, Inc.

Star Investors

7.46M

-20.05%

Geode Capital Management, L.L.C.

4.79M

+6.31%

Boston Partners

4.42M

-18.32%

Wellington Management Company, LLP

3.86M

-28.88%

Fidelity Management & Research Company LLC

2.78M

+36.98%

Managed Account Advisors LLC

2.77M

+4.52%

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 9.56, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.63. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.